4JUH image
Deposition Date 2013-03-24
Release Date 2013-05-01
Last Version Date 2024-10-30
Entry Detail
PDB ID:
4JUH
Keywords:
Title:
Crystal structure of 1918 pandemic influenza virus hemagglutinin mutant D225G complexed with avian receptor analogue LSTa
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.81 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin
Gene (Uniprot):HA
Mutations:D225G
Chain IDs:A, C, E
Chain Length:324
Number of Molecules:3
Biological Source:Influenza A virus
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin
Gene (Uniprot):HA
Chain IDs:B, D, F
Chain Length:170
Number of Molecules:3
Biological Source:Influenza A virus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN C ASN GLYCOSYLATION SITE
Peptide-like Molecules
PRD_900067
Primary Citation
Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution
J.Virol. 87 5949 5958 (2013)
PMID: 23514882 DOI: 10.1128/JVI.00545-13

Abstact

Influenza A virus uses sialic acids as cell entry receptors, and there are two main receptor forms, α2,6 linkage or α2,3 linkage to galactose, that determine virus host ranges (mammalian or avian). The receptor binding hemagglutinins (HAs) of both 1918 and 2009 pandemic H1N1 (18H1 and 09H1, respectively) influenza A viruses preferentially bind to the human α2,6 linkage receptor. A single D225G mutation in both H1s switches receptor binding specificity from α2,6 linkage binding to dual receptor binding. However, the molecular basis for this specificity switch is not fully understood. Here, we show via H1-ligand complex structures that the D225G substitution results in a loss of a salt bridge between amino acids D225 and K222, enabling the key residue Q226 to interact with the avian receptor, thereby obtaining dual receptor binding. This is further confirmed by a D225E mutant that retains human receptor binding specificity with the salt bridge intact.

Legend

Protein

Chemical

Disease

Primary Citation of related structures